Chemical Structure (Alyftrek 01)
Alyftrek Tablet, Film Coated
Product Images NDC 51167-121
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Alyftrek (NDC 51167-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Vertex Pharmaceuticals Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Alyftrek 02)
Chemical Structure (Alyftrek 03)
Principal Display Panel (4 mg/20 mg/50 mg Blister Pack Carton)
alyftrek™ is a medication available in tablet form, containing vanzacaftor, tezacaftor, and deutivacaftor in varying doses of 4mg, 20mg, or 50mg per tablet. It is recommended to take the medication as directed by your pharmacist and to ensure that each dose is taken at the same time daily. It is important to consult with your pharmacy to ensure timely supply of the medication. The tablets should be stored at room temperature between 68°F (20°C) to 77°F (25°C), with excursions permitted from 59°F to 86°F (15°C to 30°C). Remember to keep the medication out of sight and reach of children. Additionally, each patient should be provided with a Medication Guide by the pharmacist.*
Principal Display Panel (10 mg/50 mg/125 mg Blister Pack Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
